Steroids used in early stages of COVID-19 diagnosis could prevent need for ventilator, Henry Ford study says


A new research study from researchers at Henry Ford Health System shows that the use of corticosteroids to treat COVID-19 patients proved promising.

The study took place during the early spread of the virus, back in March.

The study was published in May 2020 in Clinical Infectious Disease. Henry Ford medical experts found that the early use of methylprednisolone, or Medrol, prevented more patients from being admitted to ICU, being intubated and put on a ventilator and dying, a release states.

“We found that use of methylprednisolone early in hospitalization can beneficially affect the body’s immune reaction and systemic inflammatory responses – the cytokine storm – in COVID-19,” said study author Dr. Mayur Ramesh, Senior Staff Physician in the Henry Ford Health System Division of Infectious Disease at Henry Ford Hospital in Detroit.

The drug is FDA-approved, and is usually used to decrease immune response that results in swelling, pain and allergic-type reactions. It’s commonly used as a treatment for blood disorders, arthritis, allergic reactions, and other immune system disorders. US SPREAD GOOD NEWS!

I run this site in my spare time and thoroughly enjoy giving you all positive news!  If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.